Literature DB >> 9673263

Induction of protective immunity in rabbits by coadministration of inactivated Pasteurella multocida toxin and potassium thiocyanate extract.

L Z Jarvinen1, H Hogenesch, M A Suckow, T L Bowersock.   

Abstract

Pasteurella multocida is a bacterial pathogen that causes rhinitis (snuffles), pneumonia, otitis media, septicemia, metritis, and death in domestic rabbits. Currently, there are no effective vaccines to prevent infection by this organism. Subcutaneous (s.c.) immunization with either exotoxin or thiocyanate extracts of P. multocida induces partial protection in rabbits. Since disease begins at mucosal sites, induction of local immunity may be important in preventing systemic disease. Little is known concerning the efficacy of intranasal (i.n. ) administration of these antigens in inducing protective mucosal immunity to P. multocida in rabbits. The purpose of this study was twofold: (i) to investigate the effectiveness of vaccination with purified P. multocida toxin (PMT) and a potassium thiocyanate extract of P. multocida (CN) in combination and (ii) to evaluate the efficacy of administration of these antigens i.n. versus s.c. Forty-eight rabbits were randomly divided into eight different treatment groups. Rabbits received either one or both antigens by either s.c. or i.n. administration. Following vaccination, each group received an i.n. challenge of P. multocida. Rabbits vaccinated with both antigens i.n. or s.c. had a 100% survival rate, few or no bacteria in the liver and lungs, high serum immunoglobulin G (IgG) and IgM antibody titers, and significant numbers of IgG antibody-secreting cells (ASC) in the spleen and tracheobronchial lymph node. Rabbits vaccinated i.n. had significant nasal and bronchoalveolar lavage IgA antibody levels. Rabbits vaccinated with only one antigen, either PMT or CN, had lower antibody titers, moderate to severe liver and lung infections, and fewer ASC compared to rabbits receiving both antigens. Rabbits in the control groups had moderate to severe liver and lung infections. This study indicates that i.n. immunization with both PMT and CN induces an effective response against homologous P. multocida challenge.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9673263      PMCID: PMC108418     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

Review 1.  Pasteurella multocida toxin. The characterisation of the toxin and its significance in the diagnosis and prevention of progressive atrophic rhinitis in pigs.

Authors:  N T Foged
Journal:  APMIS Suppl       Date:  1992

2.  Comparison of penicillin and gentamicin for treatment of pasteurellosis in rabbits.

Authors:  D J Gaertner
Journal:  Lab Anim Sci       Date:  1991-01

3.  The epithelium overlying rabbit bronchus-associated lymphoid tissue does not express the secretory component of immunoglobulin A.

Authors:  I Gehrke; R Pabst
Journal:  Cell Tissue Res       Date:  1990-02       Impact factor: 5.249

Review 4.  The common mucosal immune system and current strategies for induction of immune responses in external secretions.

Authors:  J Mestecky
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

5.  Atrophic rhinitis in New Zealand white rabbits infected with Pasteurella multocida.

Authors:  R F DiGiacomo; B J Deeb; W E Giddens; B L Bernard; M M Chengappa
Journal:  Am J Vet Res       Date:  1989-09       Impact factor: 1.156

6.  Recombinant derivatives of Pasteurella multocida toxin: candidates for a vaccine against progressive atrophic rhinitis.

Authors:  S K Petersen; N T Foged; A Bording; J P Nielsen; H K Riemann; P L Frandsen
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

7.  Differentiation of field isolates of Pasteurella multocida serotype 3,4 from live vaccine strain by genotypic characterization.

Authors:  K P Snipes; D C Hirsh; R W Kasten; T E Carpenter; D W Hird; R H McCapes
Journal:  Avian Dis       Date:  1990 Apr-Jun       Impact factor: 1.577

8.  A potassium thiocyanate extract vaccine prepared from Pasteurella multocida 3:A protects rabbits against homologous challenge.

Authors:  Y S Lu; S P Pakes; L Massey; C Stefanu
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

9.  Characterization of the immunogenicity of formaldehyde detoxified Pasteurella multocida toxin.

Authors:  A Bording; N T Foged
Journal:  Vet Microbiol       Date:  1991-11       Impact factor: 3.293

10.  Transmission of Pasteurella multocida in rabbits.

Authors:  R F DiGiacomo; C D Jones; C M Wathes
Journal:  Lab Anim Sci       Date:  1987-10
View more
  3 in total

Review 1.  Pasteurella multocida: from zoonosis to cellular microbiology.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

2.  Immunostimulant effect of Egyptian propolis in rabbits.

Authors:  Somya A Nassar; Amira H Mohamed; Hamdy Soufy; Soad M Nasr; K M Mahran
Journal:  ScientificWorldJournal       Date:  2012-05-02

Review 3.  Comparative models for human nasal infections and immunity.

Authors:  Elisa Casadei; Irene Salinas
Journal:  Dev Comp Immunol       Date:  2018-12-01       Impact factor: 3.636

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.